Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Plan B launches “strong”

This article was originally published in The Tan Sheet

Executive Summary

Barr Pharmaceuticals says "strong sales" of Plan B emergency contraceptive following its November launch contributed to a 22% increase in sales of the firm's proprietary products during its fiscal 2007 second quarter. In a Feb. 28 earnings call, the company said proprietary product sales for the October-December period increased $17 million from the year-ago period to $98 million. The firm declined to provide Plan B sales details, but Chairman and CEO Bruce Downey said the product "is up substantially ... year over year as a result of the OTC switch." Downey said Barr's three-year exclusivity for Plan B began with its launch, but the firm is "evaluating the options that we have for protecting that franchise beyond" its patents (1"The Tan Sheet," Nov. 13, 2006, p. 8)...
Advertisement

Related Content

Plan B Ruling: Little Commercial Impact, Big Policy Implications
Sales & Earnings In Brief
Dual Package Plan B Hits Shelves Mid-November With Three-Year Exclusivity
Dual Package Plan B Hits Shelves Mid-November With Three-Year Exclusivity

Topics

Advertisement
UsernamePublicRestriction

Register

PS100283

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel